Search

Your search keyword '"Holze F"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Holze F" Remove constraint Author: "Holze F"
48 results on '"Holze F"'

Search Results

3. Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants

10. Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research.

11. Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response.

12. Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine.

13. Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants.

14. LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up.

15. Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.

17. Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.

18. Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA Administration.

19. Pharmacokinetics, pharmacodynamics and urinary recovery of oral lysergic acid diethylamide administration in healthy participants.

20. The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.

21. Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.

22. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.

23. Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.

24. The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity.

25. Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.

26. Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants.

27. Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants.

28. Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

29. Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration.

30. Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.

31. Safety pharmacology of acute LSD administration in healthy subjects.

32. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.

33. Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.

35. Dosing Psychedelics and MDMA.

36. Role of the 5-HT 2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin.

37. Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis.

38. A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.

39. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.

40. Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.

41. MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens.

42. Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.

43. Treatment of a Complex Personality Disorder Using Repeated Doses of LSD-A Case Report on Significant Improvements in the Absence of Acute Drug Effects.

44. Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers.

45. Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans.

46. Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.

47. Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects.

48. Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images.

Catalog

Books, media, physical & digital resources